Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

EUSA Pharma

EUSA Pharma?uq=3Oe4kK1Z
2006 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
6 FINANCING ROUNDS
5 INVESTMENTS
Description

Developer of late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol® for the treatment of oral mucositis, a common and debilitating side‐effect of radio therapy and high dose chemotherapy, Erwinase® and Kidrolase® for the treatment of acute lymphoblastic leukemia, Collatamp® G, a surgical implant impregnated with the antibiotic gentamicin, ProstaScint® for imaging the extent and spread of prostate cancer and Quadramet® for the treatment of pain in patients whose cancer has spread to the bones.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Distributors/Wholesale
Other Industries
Pharmaceuticals
Primary Office
  • Ground Floor, Suite GE
  • Breakspear Park Breakspear Way
  • Hemel Hempstead HP2 4TZ
  • England

+44 0330 000 0000

EUSA Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore EUSA Pharma‘s full profile, request access.

Request full access to PitchBook

EUSA Pharma Investments (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 18-Jul-2018 0000000000 00000 Drug Discovery
0000000 000000000 04-Oct-2016 0000000000 Buildings and Property 000 000000
0000000 000000 (00 12-Apr-2016 000000000 00000 00 Pharmaceuticals 000 000000
0000000 08-May-2008 0000000000 0000 Pharmaceuticals 00000 000000
OPi 22-Mar-2007 Buyout/LBO Real Estate Services (B2C) 0000 000000
To view this company’s complete investment and acquisition history, request access »

EUSA Pharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore EUSA Pharma‘s full profile, request access.

Request full access to PitchBook

EUSA Pharma Executive Team (5)

Name Title Board
Seat
Contact
Info
Lee Morley Chief Executive Officer & Member of the Board of Directors
Emma Johnson Chief Financial Officer & Member of the Board of Directors

3 Former Executives

You’re viewing 2 of 5 executives. Get the full list »